The GOLPH3 oncoprotein is highly expressed in HCC, where it increases the BCL-2/Bax ratio and promotes sorafenib resistance by upregulating the exosomal level of miR-494-3p and enhancing PTEN targeting [149]. The gene discussed is BCL2; the disease is hepatocellular carcinoma.